IL-33 receptor ST2 amplifies the expansion of NK cells and enhances host defense during mouse cytomegalovirus infection

Journal of Immunology

Volumn 194, Issue 12, 2015, Pages 5948-5952

  Nabekura, Tsukasa ^a,b   Girard, Jean Philippe ^c   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 33; INTERLEUKIN RECEPTOR; PROTEIN ST2; UNCLASSIFIED DRUG; IL1RL1 PROTEIN, MOUSE; IL33 PROTEIN, MOUSE; INTERLEUKIN DERIVATIVE;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DIFFERENTIATION; CELL EXPANSION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; FLOW CYTOMETRY; HOST RESISTANCE; IN VITRO STUDY; MEMORY CELL; MOUSE; MURINE CYTOMEGALOVIRUS; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STROMA CELL; UPREGULATION; VIRUS LOAD; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; GENETICS; HERPES VIRUS INFECTION; HOST PATHOGEN INTERACTION; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; IMMUNOPHENOTYPING; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; MUROMEGALOVIRUS; PHENOTYPE; SPLEEN;

ANIMALS; DISEASE MODELS, ANIMAL; HERPESVIRIDAE INFECTIONS; HOST-PATHOGEN INTERACTIONS; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-33; INTERLEUKINS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MUROMEGALOVIRUS; PHENOTYPE; RECEPTORS, INTERLEUKIN; SPLEEN; STROMAL CELLS;

EID: 84931469546     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1500424     Document Type: Article

References (27)

1. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274.
2. Cooper, M. A., J. M. Elliott, P. A. Keyel, L. Yang, J. A. Carrero, and W. M. Yokoyama. 2009. Cytokine-induced memory-like natural killer cells. Proc. Natl. Acad. Sci. USA 106: 1915-1919.
3. Min-Oo, G., Y. Kamimura, D. W. Hendricks, T. Nabekura, and L. L. Lanier. 2013. Natural killer cells: walking three paths down memory lane. Trends Immunol. 34: 251-258.
4. O'Leary, J. G., M. Goodarzi, D. L. Drayton, and U. H. von Andrian. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7: 507-516.
5. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
6. Nabekura, T., and L. L. Lanier. 2014. Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J. Exp. Med. 211: 2455-2465.
7. + NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 189: 5082-5088.
8. hi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
9. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
10. Nabekura, T., M. Kanaya, A. Shibuya, G. Fu, N. R. Gascoigne, and L. L. Lanier. 2014. Costimulatory molecule DNAM-1 is essential for optimal differentiation of memory natural killer cells during mouse cytomegalovirus infection. Immunity 40: 225-234.
11. Sun, J. C., S. Madera, N. A. Bezman, J. N. Beilke, M. H. Kaplan, and L. L. Lanier. 2012. Proinflammatory cytokine signaling required for the generation of natural killer cell memory. J. Exp. Med. 209: 947-954.
12. Cayrol, C., and J. P. Girard. 2014. IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr. Opin. Immunol. 31: 31-37.
13. Pichery, M., E. Mirey, P. Mercier, E. Lefrancais, A. Dujardin, N. Ortega, and J. P. Girard. 2012. Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J. Immunol. 188: 3488-3495.
14. Palmer, G., and C. Gabay. 2011. Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol 7: 321-329.
15. Bourgeois, E., L. P. Van, M. Samson, S. Diem, A. Barra, S. Roga, J. M. Gombert, E. Schneider, M. Dy, P. Gourdy, et al. 2009. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur. J. Immunol. 39: 1046-1055.
16. Smithgall, M. D., M. R. Comeau, B. R. Yoon, D. Kaufman, R. Armitage, and D. E. Smith. 2008. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int. Immunol. 20: 1019-1030.
17. Sesti-Costa, R., G. K. Silva, J. L. Proença-Módena, D. Carlos, M. L. Silva, J. C. Alves-Filho, E. Arruda, F. Y. Liew, and J. S. Silva. 2013. The IL-33/ST2 pathway controls coxsackievirus B5-induced experimental pancreatitis. J. Immunol. 191: 283-292.
18. Hoshino, K., S. Kashiwamura, K. Kuribayashi, T. Kodama, T. Tsujimura, K. Nakanishi, T. Matsuyama, K. Takeda, and S. Akira. 1999. The absence of interleukin 1 receptor-related T1/ST2 does not affect T helper cell type 2 development and its effector function. J. Exp. Med. 190: 1541-1548.
19. Fodil-Cornu, N., S. H. Lee, S. Belanger, A. P. Makrigiannis, C. A. Biron, R. M. Buller, and S. M. Vidal. 2008. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. J. Immunol. 181: 6394-6405.
20. Bakker, A. B., R. M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R. Murray, L. H. Phillips, J. D. Sedgwick, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13: 345-353.
21. Fletcher, A. L., D. Malhotra, S. E. Acton, V. Lukacs-Kornek, A. Bellemare-Pelletier, M. Curry, M. Armant, and S. J. Turley. 2011. Reproducible isolation of lymph node stromal cells reveals site-dependent differences in fibroblastic reticular cells. Front. Immunol. 2: 35.
22. Polumuri, S. K., G. G. Jayakar, K. A. Shirey, Z. J. Roberts, D. J. Perkins, P. M. Pitha, and S. N. Vogel. 2012. Transcriptional regulation of murine IL-33 by TLR and non-TLR agonists. J. Immunol. 189: 50-60.
23. Tabeta, K., P. Georgel, E. Janssen, X. Du, K. Hoebe, K. Crozat, S. Mudd, L. Shamel, S. Sovath, J. Goode, et al. 2004. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 101: 3516-3521.
24. Hsu, K. M., J. R. Pratt, W. J. Akers, S. I. Achilefu, and W. M. Yokoyama. 2009. Murine cytomegalovirus displays selective infection of cells within hours after systemic administration. J. Gen. Virol. 90: 33-43.
25. Grégoire, C., C. Cognet, L. Chasson, C. A. Coupet, M. Dalod, A. Reboldi, J. Marvel, F. Sallusto, E. Vivier, and T. Walzer. 2008. Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation. Eur. J. Immunol. 38: 2076-2084.
26. Hunter, C. A., R. Chizzonite, and J. S. Remington. 1995. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens. J. Immunol. 155: 4347-4354.
27. Madera, S., and J. C. Sun. 2015. Cutting edge: stage-specific requirement of IL-18 for antiviral NK cell expansion. J. Immunol. 194: 1408-1412.